Nata Bakaradze
About Nata Bakaradze
Nata Bakaradze is a Clinical Protocol Manager specializing in oncology at Bristol-Myers Squibb, with extensive experience in clinical site management.
Current Position at Bristol-Myers Squibb
Nata Bakaradze currently serves as a Clinical Protocol Manager, Oncology at Bristol-Myers Squibb. In this role, Nata oversees the management of clinical protocols, ensuring adherence to regulatory requirements and the efficient conduct of clinical trials in oncology. This involves coordinating various aspects of clinical studies, including protocol development, implementation, and performance monitoring.
Role as Clinical Site Manager in New York
In addition to the role of Clinical Protocol Manager, Nata Bakaradze also holds the position of Clinical Site Manager - Oncology at Bristol-Myers Squibb in New York, New York. This role emphasizes overseeing clinical trial sites, managing site activities, ensuring compliance with clinical trial protocols, and liaising between the sites and the central study team.
Education and Medical Background
Nata Bakaradze pursued medical education at the University of St. Petersburg, where she attained a Doctor of Medicine degree. Additionally, Nata studied at Saint Petersburg State Pavlov Medical University, earning another Doctor of Medicine degree. These academic qualifications underpin her expertise in the medical and clinical research fields, especially in oncology.
Experience in Clinical Protocol Management
Nata Bakaradze has specialized in managing clinical protocols within the oncology sector. Her extensive experience includes overseeing the development, execution, and monitoring of clinical research protocols, ensuring that studies align with regulatory standards and research objectives. Her role is critical to the success of clinical trials, facilitating the accurate and efficient collection of data.
Career at Bristol-Myers Squibb
Nata Bakaradze began her career at Bristol-Myers Squibb in January 2017. Over the years, she has contributed significantly to the oncology department by managing multiple clinical trials and site activities. Her work supports the advancement of oncology research and aligns with the company's mission to discover, develop, and deliver innovative medicines.